No Data
UBS Adjusts Viatris Price Target to $23 From $20
Most Healthcare Companies Report Higher Y/Y EPS in Strong Earnings Week
RFK Jr. Wants Fewer Americans On Antidepressants — Here's Why The Debate Is Exploding
Research Alert: CFRA Keeps Hold Opinion On Shares Of Viatris Inc.
Truist Securities Maintains Buy on Viatris, Raises Price Target to $20
Daily short sale tracking: B2Gold's short volume increased by 7 million, with a short sale ratio of 15%
B2Gold(BTG.US) ranked top of the list had the largest change in short volume (7.56 million shares), and the short volume ratio of ING Groep(ING.US) reached 48.33%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.